You are invited to join a virtual event seeking to discuss the economic and societal value of intellectual property rights (IPRs) for Europe.
How do IPRs in EU Free Trade Agreements (FTAs) support EU strategic resilience and global competitiveness in a post-COVID world? What are the concrete benefits of robust IPRs for EU member states? How important is IP for innovation, in particular for the green and digital societal transformations? Why should IPRs be given a more prominent role in EU policy making, especially when it comes to EU FTAs? These are some of the questions that our guest speakers will address during the panel discussion.
Following the presentation of a recent ECIPE report, the speakers will explore how stronger IPR provisions in EU FTAs contribute to EU and EU Member State economic and societal ambitions.
Speakers:
If you have any questions or require additional information, please contact ECIPE at events@ecipe.org
We look forward to virtually meeting you on 11 January!
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.